The proposed project will assess long-term changes to health/lifestyle, advanced planning, and research engagement that Black and White patients with Amnestic Mild Cognitive Impairment (aMCI) make following disclosure of positron emission tomography-based amyloid and tau burden and associated risk of conversion to Dementia-Alzheimer's Type. Healthcare access will be explored as potential barrier to or facilitator of behavior change.
Age range
50 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Post-disclosure health behavior change as measured by the health behavior subscale score
Timeframe: 6 months
Post-disclosure health behavior change as measured by the health communication subscale score
Timeframe: 6 months
Post-disclosure health behavior change as measured by the advanced planning subscale score
Timeframe: 6 months
Post-disclosure health behavior change as measured by the research engagement subscale score
Timeframe: 6 months
Percent participant retention in University of Michigan Memory and Aging Project (UMMAP) study
Timeframe: Up to 24 months